Targets prohibitin on blood vessels specifically within white adipose tissue. KGGRAKD sequence homes to adipose vasculature; GD amino acids induce apoptosis in targeted vessels.
Studies have administered: Primate studies: 0.56mg/kg daily for 28 days; human data extremely limited
NHP studies showed 11% body weight reduction and 27% BMI decrease in 28 days. Kidney toxicity observed at high doses in primate models — significant safety consideration noted in research.
Kidney toxicity documented in primate studies at high doses — critical safety consideration flagged in all research publications
These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.
Want a Complete Research Monograph?
Our AI can generate a 2,000+ word deep-dive on Adipotide (FTPP) — including full clinical trial summaries, pharmacokinetics, and research frontiers.
Generate Deep Dive in Research Chat